Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study
Abdominal Radiology · 2024
DOI: 10.1007/s00261-024-04308-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Jae-Sung Yoo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bevacizumab, Infusions, Intra-Arterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591, Republic of Korea.
- Department of Internal Medicine, Yeungnam University Medical Center, 170, Hyeonchung-ro, Nam-gu, Daegu, 42415, Republic of Korea.
- Department of Gastroenterology and Hepatology, Uijeongbu St Mary's Hospital, The Catholic University of Korea, 271, Cheonbo-ro, Uijeongbu-si, Gyeonggi, 11765, Republic of Korea.
- Department of Radiology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea.
- Department of Gastroenterology and Hepatology, Seoul St Mary's Hospital, The Catholic University of Korea, 222, Banpo-daero, Seocho-gu, Seuol, 06591, Republic of Korea. pssung@catholic.ac.kr.
ORCID-Profile: Pil Soo Sung
Förderung
- National Research Foundation of Korea
Zitieren
APA
Yoo, J. S., Kim, J. H., Cho, H. S., Han, J. W., Jang, J. W., Choi, J. Y., Yoon, S. K., Kim, S., Oh, J. S., Chun, H. J., & Sung, P. S. (2024). Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04308-6
Vancouver
Yoo JS, Kim JH, Cho HS, Han JW, Jang JW, Choi JY, et al. Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04308-6
BibTeX
@article{Yoo2024,
author = {Yoo, Jae-Sung and Kim, Ji Hoon and Cho, Hee Sun and Han, Ji Won and Jang, Jeong Won and Choi, Jong Young and Yoon, Seung Kew and Kim, Suho and Oh, Jung Suk and Chun, Ho Jong and Sung, Pil Soo},
title = {Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study},
journal = {Abdominal Radiology},
year = {2024},
doi = {10.1007/s00261-024-04308-6}
}
EUVIMED